top of page
Respiratory pathogen testing
RIT
Acutis Reveal™ respiratory infection test (RIT) quickly identifies pathogens, determines what is present, and most importantly, answers questions as to whether the infection is viral
or bacterial in nature.
Our FDA-approved method can detect up to 22 major respiratory pathogens
often returning results the same day we receive the sample.
I would like to be contacted by an Acutis Expert
Molecular detection of infectious diseases
eases and expedites the process
Sensitivity
Specificity
Additional confirmation requirements
Subtype detection of pathogens
Number of pathogens tested
Turnaround time
Acutis Reveal™ RIT
95%
100%
No
Yes
22
Within 24 hours of sample receipt
Culture
In-office test
83.4% (68-98.8%)
100%
No
Yes
1
24 hours to 10 days
60% (50-70%)
90%
Yes
No
1
Same day
The FDA-approved test can detect
up to 22 major respiratory pathogens
Acutis Reveal™ viral targets
Acutis Reveal™ bacterial targets
-
Chlamydophila pneumoniae
-
Mycoplasma pneumoniae
-
Bordetella pertussis
-
Bordetella parapertussis
-
Adenovirus
-
Coronavirus HKU1
-
Coronavirus NL63
-
Coronavirus 229E
-
Coronavirus OC43
Human bocavirus -
Human metapneumovirus
-
Influenza A
-
Influenza A H1
-
Influenza A H3
-
Influenza B
-
Parainfluenza virus 1
-
Parainfluenza virus 2
-
Parainfluenza virus 3
-
Parainfluenza virus 4
-
Respiratory syncytial virus A
-
Respiratory syncytial virus B
-
Rhinovirus / Enterovirus
Benefits of Acutis Reveal™ RIT at a glance
Prevention of misdiagnoses and subsequent inappropriate use of antibiotics
Delivery of 95% of results the same day we receive the sample
Precise subtype detection of key pathogens
Access to infectious disease and microbiology specialists
Clinical insights
Is it a flu, or is it COVID?
Until quite recently, physicians and patients alike need a clear answer to the question: "is it just a cold, or is the flu?"
The emergence of COVID-19 has changed the conversation.
​
"Is it the flu, or is it COVID?" Although there are key differences between the two, flu and COVID-19 share many superficial characteristics. Fever, cough, difficulty breathing, and fatigue are symptoms commonly associated with both diseases. These similarities mean symptoms alone offer physicians little guidance.
To complicate the matter furthermore, undiagnosed co-infection with respiratory pathogens, such as COVID-19 and bacterial pneumonia, can develop into acute respiratory distress syndrome (ARDS). The diagnosis and subsequent therapeutic response differ significantly depending on which infections are identified. For these reasons, testing may be needed to help confirm a diagnosis and provide insight into the best path for treatment.
bottom of page